InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026)
InfuSystem Holdings (INFU) reported Asset Writedowns and Impairment of $202000.0 for Q1 2026, up 348.89% on a YoY basis from $45000.0 in Q1 2025, and up 247.45% quarter-over-quarter from -$137000.0 in Q4 2025.
InfuSystem Holdings (INFU) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Asset Writedowns and Impairment for 11 years, with the latest figure at $202000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 348.89% year-over-year to $202000.0; the trailing twelve-month figure through Mar 2026 stood at $357000.0 (up 551.9% YoY), and the FY2025 full-year result was $200000.0, up 219.76% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $202000.0, up from -$137000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $450000.0 in Q1 2023, with the low at -$845000.0 in Q4 2024.
- Historically, Asset Writedowns and Impairment has averaged $57882.4 across 5 years, with a median of $45000.0 in 2025.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment tumbled 1000.0% — and 2023, when it surged 857.45%.
- InfuSystem Holdings' Asset Writedowns and Impairment stood at $171000.0 in 2022, then soared by 161.99% to $448000.0 in 2023, then tumbled by 288.62% to -$845000.0 in 2024, then surged by 83.79% to -$137000.0 in 2025, then surged by 247.45% to $202000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $202000.0 (Q1 2026), -$137000.0 (Q4 2025), and $298000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,000.00 |
| Mar 31, 2026 | 202,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Sep 30, 2025 | 298,000.00 |
| Sep 30, 2025 | 298,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Jun 30, 2025 | -6,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Mar 31, 2025 | 45,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Dec 31, 2024 | -845,000.00 |
| Sep 30, 2024 | 362,000.00 |
| Sep 30, 2024 | 362,000.00 |
| Jun 30, 2024 | 359,000.00 |
| Jun 30, 2024 | 359,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Mar 31, 2024 | -43,000.00 |
| Dec 31, 2023 | 448,000.00 |
| Dec 31, 2023 | 448,000.00 |